Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

Go back to Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
Sangamo Biosciences, Inc. (NASDAQ: SGMO) Delayed: 0.18 --0 (-0%)
Previous Close $0.18    52 Week High $9.91 
Open $0.18    52 Week Low $3.10 
Day High $0.18    P/E N/A 
Day Low $0.18    EPS $-0.48 
Volume 54,776,712